| Literature DB >> 32192033 |
Javiera Mujica-Álvarez1,2, O Gil-Castell3,4, Pabla A Barra5, A Ribes-Greus3, Rubén Bustos2, Mirko Faccini5,6, Silvia Matiacevich1.
Abstract
Encapsulated fat-soluble powders containing vitamin A (VA) and E (VE) were prepared as a feasible additive for extruded feed products. The effect of the encapsulating agents (Capsul-CAP®, sodium caseinate-SC) in combination with Tween 80 (TW) as an emulsifier and maltodextrin (MD) as a wall material on the physicochemical properties of emulsions and powders was evaluated. First, nanoemulsions containing MD:CAP:TW:VA/VE and MD:SC:TW:VA/VE were prepared and characterized. Then, powders were obtained by means of spray-drying and analyzed in terms of the product yield, encapsulation efficiency, moisture content, porosity, surface morphology, chemical structure, and thermal properties and thermo-oxidative/thermal stability. Results showed that although nanoemulsions were obtained for all the compositions, homogeneous microcapsules were found after the drying process. High product yield and encapsulation efficiency were obtained, and the presence of the vitamins was corroborated. The characteristics of the powders were mainly influenced by the encapsulating agent used and also by the type of vitamin. In general, the microcapsules remained thermally stable up to 170 °C and, therefore, the proposed encapsulation systems for vitamins A and E were suitable for the preparation of additives for the feed manufacturing through the extrusion process.Entities:
Keywords: encapsulation; nanoemulsions; spray-drying; vitamin A; vitamin E
Mesh:
Substances:
Year: 2020 PMID: 32192033 PMCID: PMC7144125 DOI: 10.3390/molecules25061357
Source DB: PubMed Journal: Molecules ISSN: 1420-3049 Impact factor: 4.411
Mean particle size and polydispersity index of Vitamin A (VA) and E (VE) nanoemulsion based on maltodextrin in combination with Capsul® (CAP) or sodium caseinate (SC) and Tween 80 (TW).
| Sample | Z-Average Size (nm) | PDI |
|---|---|---|
| MD:CAP:TW:VA | 102.5 ± 1.3 a | 0.473 ± 0.091 a |
| MD:CAP:TW:VE | 75.1 ± 0.1 b | 0.286 ± 0.050 b |
| MD:SC:TW:VA | 100.4 ± 0.2 a | 0.431 ± 0.009 a |
| MD:SC:TW:VE | 80.1 ± 2.7 c | 0.263 ± 0.004 b |
a,b,c Different letters in the same column indicate significant differences between samples (p < 0.05) analyzed using multiple comparison of Bonferroni-Dunn test.
Figure 1Scanning electron micrographs and histograms of particle size of vitamins encapsulated and controls. (a) MD:CAP:TW; (b) MD:CAP:TW:VA; (c) MD:CAP:TW:VE; (d) MD:SC:TW; (e) MD:SC:TW:VA (f) MD:SC:TW:VE.
Product yield, encapsulation efficiency, moisture content, bulk density, and particle (true) density and porosity of microcapsules. MD: Maltodextrin, CAP: Capsul®, SC: Sodium caseinate and TW: Tween 80.
| Sample | Product Yield (%) | Encapsulation Efficiency (%) | Moisture (%db) | Bulk Density (g·cm−3) | Particle Density (g·cm−3) | Porosity (%) |
|---|---|---|---|---|---|---|
| MD:CAP:TW | 80.3 ± 1.2 ab | - | 8.1 ± 1.0 b | 0.44 ± 0.01 a | 1.14 ± 0.01 a | 62 ab |
| MD:CAP:TW:VA | 81.3 ± 2.0 abc | 100 ± 5 | 5.9 ± 2.2 ab | 0.40 ± 0.01 a | 1.12 ± 0.02 a | 64 a |
| MD:CAP:TW:VE | 79.7 ± 0.7 ab | 48 ± 3 | 8.2 ± 1.2 b | 0.37 ± 0.01 a | 1.06 ± 0.01 b | 65 a |
| MD:SC:TW | 77.3 ± 1.6 a | - | 6.5 ± 1.7 b | 0.44 ± 0.05 a | 1.09 ± 0.01 ab | 60 b |
| MD:SC:TW:VA | 83.1 ± 1.4 bc | 23 ± 4 | 1.9 ± 0.8 a | 0.35 ± 0.04 a | 1.25 ± 0.21 ab | 69 c |
| MD:SC:TW:VE | 84.6 ± 0.6 c | 29 ± 5 | 4.4 ± 1.5 ab | 0.40 ± 0.03 a | 1.10 ± 0.02 ab | 64 a |
a,b,c Different letters in the same column indicate significant differences between samples (p < 0.05) analyzed using multiple comparisons of Bonferroni-Dunn test.
Figure 2Fourier transform infrared spectroscopy (FTIR) spectra of (a) encapsulating agents—maltodextrin (MD), Capsul® (CAP), sodium caseinate (SC)—and surfactant Tween 80 (TW); (b) Vitamin A (VA); and (c) Vitamin E (VE); and comparison of the vitamin encapsulation using (d) MD:CAP:TW and (e) MD:SC:TW matrices.
Figure 3First heating differential scanning calorimetry (DSC) thermograms of (a) vitamin A (VA) and vitamin E (VE); (b) MD, CAP, SC, and TW components and comparison between encapsulated vitamins using (c) MD:CAP:TW and (d) MD:SC:TW wall polymer matrices.
Peak temperature (Tp) and enthalpy values (Δh) of the main endothermic events in the first heating scan.
| Sample | Tp1 (°C) | Δh1 (J·g−1) | Tp2 (°C) | Δh2 (J·g−1) | Water Content (%) |
|---|---|---|---|---|---|
| Vitamin A (VA) | ~0 | 43.2 | - | - | - |
| Vitamin E (VE) | - | - | - | - | - |
| MD:CAP:TW | - | - | 82.1 | 155.6 | 6.4 |
| MD:CAP:TW:VA | ~0 | 0.4 | 81.4 | 157.3 | 6.5 |
| MD:CAP:TW:VE | - | - | 80.4 | 158.6 | 6.5 |
| MD:SC:TW | - | - | 77.2 | 161.2 | 6.6 |
| MD:SC:TW:VA | ~0 | 0.2 | 77.7 | 133.6 | 5.5 |
| MD:SC:TW:VE | - | - | 76.5 | 163.9 | 6.7 |
Figure 4First heating DSC thermograms of MD:CAP:TW:VA and MD:SC:TW:VA powders after 1-month storage.
Summary of the formulations achieved. Components: Maltodextrin (MD), Capsul® (CAP), sodium caseinate (SC), Tween 80 (TW), Vitamin A (VA) and E (VE).
| Samples | Wall Polymer Blends | Vitamin | Emulsifier |
|---|---|---|---|
| MD:CAP:TW:VA | MD:CAP (70:30 % w/w) | VA (1% w/w) | TW (1% w/w) |
| MD:CAP:TW:VE | VE (1% w/w) | ||
| MD:SC:TW:VA | MD:SC (70:30 % w/w) | VA (1% w/w) | |
| MD:SC:TW:VE | VE (1% w/w) |
Figure 5DTGA curves under oxidative atmosphere of (a) vitamin A (VA) and vitamin E (VE); (b) MD, CAP, SC, and TW components; and comparison of the vitamin encapsulation using (c) MD:CAP:TW and (d) MD:SC:TW matrices.
Figure 6DTGA curves under an inert atmosphere of (a) vitamin A (VA) and vitamin E (VE); (b) MD, CAP, SC, and TW components; and comparison of the vitamin encapsulation using (c) MD:CAP:TW and (d) MD:SC:TW matrices.
Figure 7Nanoemulsion preparation sequence.